John Strelow - Concepedia

Author

John Strelow

Eli Lilly (United States)

Also Known As

J M Strelow, J.M. Strelow, John M. Strelow, John Strelow

Publications

658

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

John Strelow is an author at Eli Lilly (United States) specializing in natural sciences, drug discovery, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	4	4	121
2	Medicine	3	3	107
3	Biochemistry	3	3	107
4	Education	1	1	14
5	Chemical Biology	1	1	41

John Strelow

Publications

234

Citations

H-Index

Page 1

	Year	Citations
Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F Liandong Ma, Joshua R. Clayton, Richard A. Walgren, Blood Cancer Journal	2013	64
Mechanism of Action Assays for Enzymes John Strelow, Walthère Dewé, Phillip W. Iversen, Target EnzymeDrug TargetBioorganic ChemistryMoa AssaysMedicinal Chemistry	2012	50
Abstract 1259: Preclinical characterization of LY3537982, a novel, highly selective and potent KRAS-G12C inhibitor Sheng-Bin Peng, Chong Si, Youyan Zhang, Cancer Research Drug TargetMolecular BiologyPharmacotherapyChemical BiologyPharmaceutical Chemistry	2021	41
Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor Aruna Wijeratne, Junpeng Xiao, Christopher T. Reutter, ACS Medicinal Chemistry Letters	2018	23
The identification of β-hydroxy carboxylic acids as selective MMP-12 inhibitors Ian P. Holmes, Simon Gaines, Steve P. Watson, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	2009	16
The Use of Nucleosome Substrates Improves Binding of SAM Analogs to SETD8 John Strelow, Min Xiao, Rachel N. Cavitt, SLAS DISCOVERY	2016	15
Second-Harmonic Generation (SHG) for Conformational Measurements: Assay Development, Optimization, and Screening Tracy A. Young, Ben Moree, Margaret T. Butko, Methods in enzymology on CD-ROM/Methods in enzymology MeasurementNatural SciencesSpectroscopyConformational MeasurementsMolecular Biology	2018	14
Abstract LB-274: Identification and characterization of LY3410738, a novel covalent inhibitor of cancer-associated mutant Isocitrate Dehydrogenase 1 (IDH1) Nathan A. Brooks, Robin DeWalt, Serge L. Boulet, Cancer Research	2019	11

Page 1